[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352434-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352434-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","biomimetic-hydrogel-for-the-construction-of-patient-derived-bladder-cancer-organoids-with-aggressive-growth","Biomimetic hydrogel for the construction of patient-derived bladder cancer organoids with aggressive growth","","Biomimetic hydrogel constructs patient-derived bladder cancer organoids to better reproduce tumor extracellular matrix features that drive malignancy behavior and therapy response. The study addresses limitations of existing organoid scaffolds that lack tumor-like collagen, focusing on cellulose microfibibers (MCFs) as mesoscale collagen mimics. The resulting organoids show improved viability, invasiveness, and migration, while preserving tumor architecture and mutations. Drug sensitivities align with parental tissue-derived cells and correlate with patient outcomes, supporting preclinical personalized medicine modeling.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/biomimetic-hydrogel-for-the-construction-of-patient-derived-bladder-cancer-organoids-with-aggressive-growth/352434/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/biomimetic-hydrogel-for-the-construction-of-patient-derived-bladder-cancer-organoids-with-aggressive-growth/352434.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-26","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",14,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are collagen-like scaffolds important for bladder cancer organoids?","Question",{"text":63,"@type":64},"Tumor extracellular matrix reorganization, especially collagen, shapes cancer traits. Current organoid scaffolds often lack tumor-like collagen, which limits cell growth and migration, reducing model fidelity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do cellulose microfibers (MCFs) contribute to organoid performance?",{"text":68,"@type":64},"MCFs mimic the in vivo role of mesoscale collagen, enhancing organoid viability, invasiveness, and migration in patterns aligned with tumor growth.",{"name":70,"@type":61,"acceptedAnswer":71},"What evidence links the organoids to patient-relevant drug responses?",{"text":72,"@type":64},"The organoids preserve tumor architecture and mutations. Their drug sensitivities resemble those of parental tissue-derived cells and correlate with patient outcomes, indicating utility for preclinical therapeutic strategy modeling.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352434,1790418335,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","iScience Article  \nBiomimetic hydrogel for the construction of patientderived bladder cancer organoids with aggressive growth  \nAuthors  \nJin Zhang, Jiaxin Wang, Xiaofeng Hu, ..., Hong Guo, Ling Guo, Dongwen Wang  \nCorrespondence  \n[guoling@cicams-sz.org.cn](guoling@cicams-sz.org.cn) (L.G.),  \n[urology2007@126.com](urology2007@126.com) (D.W.)  \nIn brief  \nBiological sciences; Bioengineering; Biomimetics; Stem cells research; Cancer; Biomaterials  \n• Bladder cancer organoids mimic tumor properties for personalized therapeutic models  \n• Cellulose microfibers enhance organoid viability, invasiveness, and migration  \n• Organoids preserve tumor architecture and mutations, reflecting drug sensitivities  \nZhang et al., 2026, iScience 29, 114786  \nFebruary 20, 2026 © 2026 The Authors. Published by Elsevier Inc.  \n[https://doi.org/10.1016/j.isci.2026.114786](https://doi.org/10.1016/j.isci.2026.114786)  \nll  \niScience  \nll  \nOPEN ACCESS  \nArticle  \nBiomimetic hydrogel for the construction of patient-derived bladder cancer organoids with aggressive growth  \nJin Zhang,1,2,5 Jiaxin Wang,1,5 Xiaofeng Hu,2 Wei Jia,1 Ziyuan Zhou,1 Gaohaer Kadeerhan,1 Wenmin Guo,1 Jun Tian,1 Hong Guo,3,4 Ling Guo,1,* and Dongwen Wang1,6,*  \n1National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Shenzhen, Guangdong 518116, P. R. China  \n2Shanxi Medical University, Taiyuan 030001, China  \n3Department of the First Clinical Medical College, Shanxi Medical University, Taiyuan 030001, China  \n4Department of Urology, First Hospital of Shanxi Medical University, Taiyuan, Shanxi 030001, China  \n5These authors contributed equally  \n6Lead contact  \n*Correspondence: [guoling@cicams-sz.org.cn](guoling@cicams-sz.org.cn) (L.G.), [urology2007@126.com](urology2007@126.com) (D.W.) [https://doi.org/10.1016/j.isci.2026.114786](https://doi.org/10.1016/j.isci.2026.114786)  \nSUMMARY  \nIn cancer, the extracellular matrix (ECM) reorganization, notably collagen, forming dense, thickened, and orderly structures, affects tumor traits. Bladder cancer organoids (BCOs) mimic tumor properties for personalized medicine. However, current organoid scaffolds lack tumor-such as collagen, crucial for cell growth and migration. Previous efforts to incorporate mesoscale collagen fibers extracted directly from tumors into scaffolds were limited by the size of the tumor tissue and the efficiency of extraction. In this study, we used cellulose microfibers (MCFs) to mimic in vivo mesoscale collagen’s role, enhancing BCO viability, invasiveness, and migration, aligning with tumor growth patterns. These organoids preserved tumor architecture and mutations, showing drug sensitivities similar to those of parental tissue-derived cells and correlating with patient outcomes. This suggests that such organoids can serve as preclinical models to inform therapeutic strategies.  \nINTRODUCTION  \nGlobally, bladder cancer ranks as the second most prevalent malignancy within the urogenital system, surpassed only by prostate cancer.1 It can be categorized into non-muscle-invasive (NMIBC) and muscle-invasive (MIBC), with NMIBC being the predominant form at 80% of diagnoses. The prevalent treatment for NMIBC is transurethral resection, followed by intravesical chemotherapy to enhance the therapeutic outcome.2 ,3 Nevertheless, the management of tumors in clinical settings is less than ideal, with recurrence rates estimated between 15% and 61% within the first year and escalating to 31%–78% within a five-year period.4 While MIBC is relatively rare, its treatment necessitates aggressive measures such as radical cystectomy or chemotherapy, which can profoundly affect the patient’s wellbeing.5 Additionally, the propensity for metastasis frequently emerges as the primary determinant of mortality in such cases.6 Hence, establishing a reliable model is essential for delving into the root causes of bladder cance","cbCailwqjjvzWIpr","https://ap.wps.com/l/cbCailwqjjvzWIpr","pdf",20595608,22,"English","# SUMMARY\n# INTRODUCTION","[{\"question\":\"Why are collagen-like scaffolds important for bladder cancer organoids?\",\"answer\":\"Tumor extracellular matrix reorganization, especially collagen, shapes cancer traits. Current organoid scaffolds often lack tumor-like collagen, which limits cell growth and migration, reducing model fidelity.\"},{\"question\":\"How do cellulose microfibers (MCFs) contribute to organoid performance?\",\"answer\":\"MCFs mimic the in vivo role of mesoscale collagen, enhancing organoid viability, invasiveness, and migration in patterns aligned with tumor growth.\"},{\"question\":\"What evidence links the organoids to patient-relevant drug responses?\",\"answer\":\"The organoids preserve tumor architecture and mutations. Their drug sensitivities resemble those of parental tissue-derived cells and correlate with patient outcomes, indicating utility for preclinical therapeutic strategy modeling.\"}]","Biomimetic hydrogel for the construction of patient-derived bladder cancer organoids with aggressive growth | PDF",1790099584,55,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75eeb0649df7f47c9430507acb159660.webp",983,1276,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5db32645d7be35cab9ca536e1981ca2.webp",982,1275,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cc8b0c2814d68e6a026b545a77032809.webp",981,1273,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ab44882f6b1703527b7ef395aad56a6b.webp",980,1272]